Research & Development



  雲瑯對待霍去病非常的委婉,不過呢,回到營地之後,他的做法就非常的不委婉了。   明明想要把霍去病這群人安排去鉤子山,卻不願意明說,非要讓霍去病他們自己提出來才答應。精品国产自在线拍   只要站在山頂,看看四面平坦的草原,就能想象當年站在這片草原上的匈奴人的聲勢該是如何的浩大。久久国产av偷拍在线   直到此刻雲瑯終于明白了,這些人為什麼會心甘情願的成為鬼奴了,原因就是當鬼奴能夠不被餓死。   好在這里的山包,大部分都是黃土山包,即便是有一些石頭,也是紅砂岩,算不得很難挖掘。开心色综合伊人   雲瑯笑著朝謝長川點點頭就離開了土城。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo